Rare disease research
Drug development and formulation work directed toward diseases with significant unmet medical needs.
Life Science
for humanity
Advancing research and access to medicines for rare and serious diseases — because every life deserves the possibility of better care.
About Adelice
Every patient
matters
Adelice S.A. is a pharmaceutical research and development company focused on medicines for rare and serious diseases, including cystic fibrosis. We seek to connect scientific progress with practical solutions — bringing together drug development, responsible procurement, and specialized distribution.
Our guiding belief is simple: the measure of science is the difference it can make in human lives.
Compassion
Human needs at the heart of our work.
Discovery
Research directed toward unmet medical needs.
Responsibility
Quality, compliance, and thoughtful access.
What we do
From discovery
to meaningful impact
Scientific ambition matters most when it moves toward real-world implementation. Our work brings research and pharmaceutical operations together.
Scientific collaboration
Preclinical and clinical research, with opportunities to collaborate across biotechnology and academic research.
Practical delivery
Specialized procurement, quality-minded operations, and distribution to help essential medicines reach healthcare providers.
Research with purpose ✦
Our therapeutic focus
Hope for those with rare diseases
Rare diseases present complex scientific and healthcare challenges. Adelice focuses on orphan medicinal products and therapeutic approaches designed to address areas of unmet need.
Featured product · Trilexa®
Cystic fibrosis
Adelice's existing portfolio highlights Trilexa®, described as a combination of elexacaftor, tezacaftor, and ivacaftor for cystic fibrosis. Our work reflects a broader commitment to research into rare pulmonary and other serious diseases.
Learn more about rare-disease drug development in children: Michigan Medicine ↗
What guides us
“Science gives us the tools to discover. Humanity gives us the reason to begin.”
Connect with Adelice